Epidemiological characterization of Hodgkin lymphoma in patients treated at the SOLCA - Guayaquil Hospital
Descargar el PDF (Español (España))
Download the PDF
HTML
XML

Keywords

Hodgkin lymphoma
hematologic neoplasms
epidemiology

How to Cite

Real Cotto, J. J., García Gamboa, D. U., & Garcés Santos, J. C. (2024). Epidemiological characterization of Hodgkin lymphoma in patients treated at the SOLCA - Guayaquil Hospital. Oncology Journal (Ecuador), 34(1), 36–43. https://doi.org/10.33821/744

Abstract

Introduction: Hodgkin lymphoma is a disease in which malignant cells form in the lymphatic system; its presence in the population has been increasing in recent years. Objective: Epidemiological characterization of the Hodgkin lymphomas treated at the SOLCA - Guayaquil hospital during the period 2010–2021. Material and methods: A study was carried out with open data from a cross-sectional observational descriptive design of the new cases of Hodgkin Lymphoma diagnosed and treated at the SOLCA - Guayaquil hospital between 2010 and 2021. Results. Hodgkin lymphoma care at the SOLCA - Guayaquil Hospital went from 4% in 2010 to 12% in 2021. Hodgkin lymphoma with nodular sclerosis was mostly observed in men; however, by age group, it was more frequent in men between 0 and 19 years old (37.7%) and in women between 20 and 29 years old (45.3%) from the Guayas province. Conclusions. During this period, Hodgkin lymphoma has garnered more attention due to an increase in nodular sclerosis cases observed in men aged 0 to 19 and women aged 20 to 39, which aligns with the standard behavior of this disease.

https://doi.org/10.33821/744
Descargar el PDF (Español (España))
Download the PDF
HTML
XML

References

Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20): 2375-90. Disponible en: https://ashpublications.org/blood/article/127/20/2375/35286/The-2016-revision-of-the-World-Health-Organization

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1): 7-34. https//doi.org/10.3322/caac.21551

Globocan. Hodgkin lymphoma [Internet]. WHO. 2020 [citado 25 de diciembre de 2022]. Disponible en: https://gco.iarc.fr/today/data/factsheets/cancers/33-Hodgkin-lymphoma-fact-sheet.pdf

Evens AM, Antillón M, Aschebrook-Kilfoy B, Chiu BCH. Racial disparities in Hodgkin’s lymphoma: a comprehensive population-based analysis. Ann Oncol. 2012;23(8): 2128-37. Disponible en: https://www.annalsofoncology.org/article/S0923-7534(19)38096-2/fulltext

Rénard C, Claude L, Garnier N, Penel-Page M. Linfoma de Hodgkin en niños y adolescentes. EMC - Pediatría. 2022;57(2): 1-14.

Pérez-Zúñiga JM, Aguilar-Andrade C, Álvarez-Vera JL, Augusto-Pacheco M, Báez-Islas PE, Bates-Martín RA, et al. Linfoma de Hodgkin. Rev Hematol. 2019;20(2): 124-30.

Grubb WR, Neboori HJ, Diaz AD, Li H, Kwon D, Panoff J. Racial and Ethnic Disparities in the Pediatric Hodgkin Lymphoma Population. Pediatr Blood Cancer 2016;63(3): 428-35. https://doi.org/10.1002/pbc.25802

Monteiro TAF, Arnaud MVC, Monteiro JLF, Costa MRM da, Vasconcelos PF da C, Monteiro TAF, et al. Linfoma de Hodgkin: aspectos epidemiológicos e subtipos diagnosticados em um hospital de referência no Estado do Pará, Brasil. Rev Pan-Amaz Saúde. 2016;7(1): 27-31. Disponible en: http://scielo.iec.gov.br/scielo.php?script=sci_abstract&pid=S2176-62232016000100003&lng=pt&nrm=iso&tlng=es

Matamoros KG, León KP, Vernaza GP, Sánchez F, Maridueña MS. Linfoma de Hodgkin del adulto: Revisión de 10 años en el Instituto Oncológico Nacional Dr. Juan Tanca Marengo. Oncol Ecuad. 2009;19(1-2): 31-5. Disponible en: https://roe.solca.med.ec/index.php/johs/article/view/431

Valdivia Flores G. Características epidemiológicas y anatomopatológicas de linfoma Hodgkin en el Hospital Goyeneche, Arequipa 2013-2018. Univ Católica St María [Internet]. 25 de marzo de 2019 [citado 14 de noviembre de 2022]; Disponible en: http://tesis.ucsm.edu.pe/repositorio/handle/UCSM/8767

Garcia K, Posligua K, Paulson G, Sánchez F, Santacruz M. Linfoma de Hodgkin del adulto: Revisión de 10 años en el Instituto Oncológico Nacional Dr. Juan Tanca Marengo. Oncol Ecuad. 2009;19(1-2): 31-5. Disponible en: https://roe-solca.ec/index.php/johs/article/view/431

López AA, Placeres LL. Caracterización clínico-epidemiológica de los pacientes con linfoma en un período de diez años en San Cristóbal. Rev Cien Estud 2019;58(271): 4-8. Disponible en: https://www.medigraphic.com/pdfs/abril/abr-2019/abr19271c.pdf

Quintero-Sierra Y, Teruel-Herrero A, Hernández-Padrón C, Concepción-Fernández Y, Romero-González A, Macia-Pérez I. Caracterización del linfoma de Hodgkin en los pacientes adultos. Rev Cuba Hematol Inmunol Hemoter. 2019;35(3): a_1027. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-02892019000300006

Monteiro TAF, Arnaud MVC, Monteiro JLF, Costa MRM da, Vasconcelos PF da C, Monteiro JLF et al. Linfoma de Hodgkin: aspectos epidemiológicos e subtipos diagnosticados em um hospital de referência no Estado do Pará, Brasil. Rev Pan-Amaz Saúde. 2016;7(1): 27-31. https://doi.org/10.5123/s2176-62232016000100003

Fiori CMCM, Rodrigues AJS, Voigt AD, Turmina L, Hata MM. Linfoma de Hodgkin em crianças e adolescentes: Estudo clínico e epidemiológico. Rev Thêma Sci. 2020;10(1E): 36-46. Disponible en: https://ojsrevistas.fag.edu.br/index.php/RTES/article/view/1206

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Copyright (c) 2024 Jhony Joe Real Cotto, Diego Ulises García Gamboa, Juan Carlos Garcés Santos

Downloads

Download data is not yet available.